RISER Meet and Greet - Phase II
Closed Special Notice Posted
- Solicitation number
- 75D30125R73218
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- R499 Support- Professional: Other
- Place of performance
- Atlanta, Georgia, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) has issued a Special Notice for a virtual meet and greet event related to the Resources for Improvement of Surveillance and Emergency Response (RISER) contract opportunity. This announcement is part of a three-phase process designed to connect large and small businesses in the In-Vitro Diagnostic Substance Manufacturing sector. The notice is specifically targeting large businesses under NAICS code 325413 who have capabilities to provide services outlined in the attached Performance Work Statement (PWS). The CDC is not soliciting proposals at this stage, but rather seeking to compile a list of qualified businesses interested in potential collaboration. This initiative is intended to facilitate networking and potential subcontracting relationships between large and small businesses in the diagnostic manufacturing industry.
The primary objective of this Special Notice is to create a structured platform for business networking and potential future contracting opportunities. Interested large businesses are required to provide a capability statement, past performance information, and indicate which parts of the PWS they might be interested in subcontracting. Small businesses will subsequently be invited to review the list of large businesses and express their interest in potential subcontracting arrangements. The event will be conducted virtually via Zoom, with the final meet and greet details to be determined based on the number of participating businesses. Eligibility is limited to businesses in the In-Vitro Diagnostic Substance Manufacturing sector, with a specific focus on large businesses in Phase I and small businesses in Phase II. The deadline for large businesses to express interest was November 14, 2024, while small businesses have until December 5, 2024, to respond. The CDC emphasizes that this is an informational process and will not reimburse any costs associated with participating in the meet and greet.
Notice text
3 versions
Update #3 · Latest ·
Amendment 2 is to extend the due date for small business interest. The tentative December 11, 2024 date for the meet and greet is no longer valid a new date will be set after Phase II closes on December 16, 2024. More information will be provided once Phase II closes and the Zoom link is provided.
This announcement is not a solicitation. This announcement does not constitute an invitation for bid, request for proposal, or request for quotation and is not to be construed as a commitment by the government. This is for informational purposes only; the government will not reimburse any costs associated with attending the meet and greet.
The CDC is seeking interested large businesses under NAICS 325413 In-Vitro Diagnostic Substance Manufacturing with the current capabilities to provide the services outlined in the attached Performance Work Statement (PWS). The intent of this announcement is to obtain a list of qualified large businesses that would be interested in providing proposals for the attached PWS. The CDC will publish the list of interested large businesses and ask for interested small businesses who could potentially provide services via subcontracts. CDC will then provide a Zoom conference line that will allow businesses to meet to begin to establish a relationship. Do not provide a proposal for this requirement; the CDC is only asking for the information listed below in the announcement at this point.
This announcement is phase one in a three-phase process that will be accomplished by the publication of this announcement and by amending it for future phases. Below is a summary of the phases:
- Phase I – call for interested large businesses.
- Phase II – publish information received from large businesses and initiate call for interested small businesses.
- Phase III – provide the link and finalized dates/times for the virtual meet and greet once the final number of large and small businesses is known.
Update #2 ·
Amendment 1 is to issue Phase II to the solicitation. This is the call for Small Business interest; see attached.
This announcement is not a solicitation. This announcement does not constitute an invitation for bid, request for proposal, or request for quotation and is not to be construed as a commitment by the government. This is for informational purposes only; the government will not reimburse any costs associated with attending the meet and greet.
The CDC is seeking interested large businesses under NAICS 325413 In-Vitro Diagnostic Substance Manufacturing with the current capabilities to provide the services outlined in the attached Performance Work Statement (PWS). The intent of this announcement is to obtain a list of qualified large businesses that would be interested in providing proposals for the attached PWS. The CDC will publish the list of interested large businesses and ask for interested small businesses who could potentially provide services via subcontracts. CDC will then provide a Zoom conference line that will allow businesses to meet to begin to establish a relationship. Do not provide a proposal for this requirement; the CDC is only asking for the information listed below in the announcement at this point.
This announcement is phase one in a three-phase process that will be accomplished by the publication of this announcement and by amending it for future phases. Below is a summary of the phases:
- Phase I – call for interested large businesses.
- Phase II – publish information received from large businesses and initiate call for interested small businesses.
- Phase III – provide the link and finalized dates/times for the virtual meet and greet once the final number of large and small businesses is known.
Update #1 ·
This announcement is not a solicitation. This announcement does not constitute an invitation for bid, request for proposal, or request for quotation and is not to be construed as a commitment by the government. This is for informational purposes only; the government will not reimburse any costs associated with attending the meet and greet.
The CDC is seeking interested large businesses under NAICS 325413 In-Vitro Diagnostic Substance Manufacturing with the current capabilities to provide the services outlined in the attached Performance Work Statement (PWS). The intent of this announcement is to obtain a list of qualified large businesses that would be interested in providing proposals for the attached PWS. The CDC will publish the list of interested large businesses and ask for interested small businesses who could potentially provide services via subcontracts. CDC will then provide a Zoom conference line that will allow businesses to meet to begin to establish a relationship. Do not provide a proposal for this requirement; the CDC is only asking for the information listed below in the announcement at this point.
This announcement is phase one in a three-phase process that will be accomplished by the publication of this announcement and by amending it for future phases. Below is a summary of the phases:
- Phase I – call for interested large businesses.
- Phase II – publish information received from large businesses and initiate call for interested small businesses.
- Phase III – provide the link and finalized dates/times for the virtual meet and greet once the final number of large and small businesses is known.
Files
| File | Type | Posted |
|---|---|---|
| Announcement - Phase II.pdf | ||
| RISER Meet and Greet Announcement Phase I.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Special Notice | |
| RISER Sources Sought | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity